Haleon plc (NYSE:HLN) Shares Sold by EP Wealth Advisors LLC

EP Wealth Advisors LLC trimmed its holdings in shares of Haleon plc (NYSE:HLN) by 10.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,110 shares of the company’s stock after selling 2,463 shares during the period. EP Wealth Advisors LLC’s holdings in Haleon were worth $166,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of HLN. Wallace Advisory Group LLC lifted its position in Haleon by 30.1% during the second quarter. Wallace Advisory Group LLC now owns 18,086 shares of the company’s stock valued at $149,000 after purchasing an additional 4,188 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Haleon by 12.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 13,281 shares of the company’s stock valued at $110,000 after buying an additional 1,450 shares during the period. Sculptor Capital LP lifted its holdings in shares of Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock valued at $73,407,000 after buying an additional 3,592,000 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of Haleon by 95.5% in the second quarter. The Manufacturers Life Insurance Company now owns 1,954,304 shares of the company’s stock worth $16,143,000 after buying an additional 954,622 shares during the last quarter. Finally, Dimension Capital Management LLC grew its holdings in Haleon by 20.5% during the second quarter. Dimension Capital Management LLC now owns 14,085 shares of the company’s stock worth $116,000 after acquiring an additional 2,392 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently weighed in on HLN shares. The Goldman Sachs Group lowered shares of Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. Morgan Stanley upped their price target on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a report on Friday, September 20th. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday. Finally, Berenberg Bank began coverage on Haleon in a research report on Tuesday, August 6th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Haleon presently has a consensus rating of “Buy” and an average price target of $10.95.

Haleon Stock Down 0.3 %

HLN opened at $10.37 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a twelve month low of $7.70 and a twelve month high of $10.80. The company has a market cap of $47.35 billion, a PE ratio of 34.57, a price-to-earnings-growth ratio of 3.12 and a beta of 0.26. The company has a 50-day moving average price of $10.09 and a 200 day moving average price of $9.02.

Haleon (NYSE:HLN) last announced its earnings results on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Haleon had a net margin of 9.71% and a return on equity of 13.15%. The firm had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion. During the same period in the previous year, the company earned $0.08 EPS. Sell-side analysts expect that Haleon plc will post 0.47 earnings per share for the current fiscal year.

Haleon Cuts Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, September 19th. Stockholders of record on Friday, August 16th were given a $0.0514 dividend. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend was Friday, August 16th. Haleon’s dividend payout ratio (DPR) is 33.33%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.